Answers are grounded in this paper and cite their sources.
Chimeric virus experiments indicated that the pathogenicity and monoclonal antibody reactivity differences between two molecularly cloned, highly passaged chicken anemia virus isolates could be attributed to the VP1 amino acid change at residue 89. The introduction of this change into a pathogenic cloned low-passage isolate was not sufficient to cause attenuation.
No takes yet. Share an insight, caveat, or question.
Todd et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: